БЕЗОПАСНОСТЬ ОДНОВРЕМЕННОГО ПРИМЕНЕНИЯ НЕПРЯМЫХ И ПРЯМЫХ АНТИКОАГУЛЯНТОВ ПРИ КАТЕРНОЙ АБЛАЦИИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ: ИССЛЕДОВАНИЕ НА БОЛЬШОЙ ГРУППЕ ПАЦИЕНТОВ

С целью ретроспективного анализа безопасности проведения катетерных вмешательств по поводу фибрилляции предсердий на фоне одновременного применения пероральных антикоагулянтов в терапевтической дозе и внутривенного введения нефракционированного гепарина проанализированы результаты лечения 310 пациентов (58%мужчин), средний возраст которых составил 53,9±10,5 (19-75) лет.

фибрилляция предсердий, радиочастотная катетерная аблация, антикоагулянтная терапия, варфарин, нефракционированный гепарин, тромбоэмболические осложнения, кровотечения

1. Calkins H., Brugada J., Packer D.L. et al. HRS/EHRA/ ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation // Heart Rhythm. - 2007. - V.4(6). - P.816-61.

2. Cappato R, Calkins H, Chen SA et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation // Circulation. - 2005. - V111. - P. 1100-1105.

3. Chen SA, Hsieh MH, Tai CT et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation // Circulation. - 1999. - V.100. - P.1879-1886.

4. Chen SA, Tai CT. Catheter ablation of atrial fibrillation originating from the non-pulmonary vein foci // J. Cardio-vasc. Electrophysiol. - 2005. - V.16. - P.229-232.

5. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) // J. Am. Coll. Cardiol. - 2006. -V.48. - P.e149-246.

6. Ghaye B, Szapiro D, Dacher JN et al. Percutaneous ablation for atrial fibrillation: the role of crosssectional imaging // Radiographics. - 2003. - V.23. - P.S19-S33.

7. Haissaguerre M, Shah DC, Jais P et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins // Circulation. - 2000. - V.102. - P.2463-2465.

8. Lickfett L, Hackenbroch M, Lewalter T et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation // J. Cardiovasc. Electrophysiol. - 2006. - V.17. - P. 1-7.

9. Maleki K, Mohammadi R, Hart D et al. Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention. J. Cardiovasc. Electrophysiol. - 2005. - V.16. - P.561-565.

10. Marrouche NF, Dresing T, Cole C et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies // J. Am. Coll. Cardiol. - 2002. - V.40. - P.464-474.

11. Oral H, Chugh A, Good E et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation // Circulation. - 2006. - V.113. - P. 1824-1831.

12. Oral H, Chugh A, Ozaydin M et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial. Fibrillation // Circulation. - 2006. - V.114. - P. 759 -765.

13. Oral H, Knight BP, Ozaydin M et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights // Circulation. - 2002. - V.106. - P. 1256 -1262.

14. Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study // J. Am. Coll. Cardiol. - 2003. - V.42. - P. 185-197.

15. Ren JF, Marchlinski FE, Callans DJ et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast // J. Cardiovasc. Electrophysiol. - 2005. - V.16. - P.474-477.

16. Wazni OM, Beheiry S, Fahmy T et al. Atrial Fibrillation Ablation in Patients With Therapeutic International Normalized Ratio // Circulation. - 2007. - V.116. - P.2531-2534.

17. Wazni OM, Rossillo A, Marrouche NF et al. Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging // J. Cardiovasc. Electrophysiol. - 2005. - V.16. - P.576-581.